AMOXAPEN Film-coated tablet Ref.[50306] Active ingredients: Amoxicillin

Source: Υπουργείο Υγείας (CY)  Revision Year: 2017  Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus

4.1. Therapeutic indications

Amoxapen is indicated for the treatment of the following infections in adults and children (see section 4.2, 4.4, 5.1):

  • acute bacteria sinusitis.
  • acute otitis media.
  • acute streptococcal tonsillitis and pharyngitis.
  • acute exacerbations of chronic bronchitis.
  • community acquired pneumonia.
  • acute cystitis.
  • asymptomatic bacteriuria in pregnancy.
  • acute pyelonephritis.
  • typhoid and paratyphoid fever.
  • dental abscess with spreading cellulitis.
  • prosthetic joint infections.
  • Helicobacter pylori eradication.
  • Lyme disease.

Amoxapen is also indicating for the prophylaxis of endocarditis.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

4.2. Posology and method of administration

Posology

The dose of Amoxapen that is selected to treat an individual infection should take into account:

  • the expected pathogens and their likely susceptibility to antibacterial agents (see section 4.4)
  • the severity and the site of the infection
  • the age, weight and renal function of the patient; as shown below

The duration of therapy should be determined by the type of infection and the response of the patient, and should generally be as short as possible. Some infections require longer periods of treatment (see section 4.4 regarding prolonged therapy).

Adults and children ≥40 kg

Indication* Dose*
Acute bacterial sinusitis250 mg to 500 mg every 8 hours or 750 mg
to 1 g every 12 hours
Asymptomatic bacteriuria in pregnancy
Acute pyelonephritis
Dental abscess with spreading cellulitisFor severe infections 750 mg to 1 g every
8 hours
Acute cystitisAcute cystitis may be treated with 3 g
twice daily for one day
Acute otitis media500 mg every 8 hours, 750 mg to 1 g every
12 hours
Acute streptococcal tonsillitis and pharyngitisFor severe infections 750 mg to 1 g every
8 hours for 10 days
Acute exacerbations of chronic
bronchitis
Community acquired pneumonia500 mg to 1 g every 8 hours
Typhoid and paratyphoid fever500 mg to 2 g every 8 hours
Prosthetic joint infections500 mg to 1 g every 8 hours
Prophylaxis of endocarditis2 g orally, single dose 30 to 60 minutes
before procedure
Helicobacter pylori eradication750 mg to 1 g twice daily in combination
with a proton pump inhibitor
(e.g. omeprazole, lansoprazole) and another
antibiotic (e.g. clarithromycin,
etronidazole) for 7 days
Lyme disease (see section 4.4) Early stage: 500 mg to 1 g every 8 hours
up to a maximum of 4 g/day in divided
doses for 14 days (10 to 21 days)

Late stage (systemic involvement): 500 mg
to 2 g every 8 hours up to a maximum of
6 g/day in divided doses for 10 to 30 days

* Consideration should be given to the official treatment guidelines for each indication

Children <40 kg

Children may be treated with Amoxapen capsules and powder for oral suspension.

Amoxapen 125 mg/5 ml powder for oral suspension is recommended for children under six months of age.

Children weighing 40 kg or more should be prescribed the adult dosage.

Recommended doses:

Indication+ Dose+
Acute bacterial sinusitis20 to 90 mg/kg/day in divided doses*
Acute otitis media
Community acquired pneumonia
Acute cystitis
Acute pyelonephritis
Dental abscess with spreading cellulitis
Acute streptococcal tonsillitis and pharyngitis40 to 90 mg/kg/day in divided doses*
Typhoid and paratyphoid fever100 mg/kg/day in three divided doses
Prophylaxis of endocarditis50 mg/kg orally, single dose 30 to
60 minutes before procedure
Lyme disease (see section 4.4) Early stage: 25 to 50 mg/kg/day in
three divided doses for 10 to 21 days

Late stage (systemic involvement):
100 mg/kg/day in three divided doses
for 10 to 30 days

+ Consideration should be given to the official treatment guidelines for each indication.
* Twice daily dosing regimens should only be considered when the dose is in the upper range.

Elderly

No dose adjustment is considered necessary.

Renal impairment

GFR (ml/min) Adults and children ≥40 kgChildren <40 kg#
greater than 30no adjustment necessaryno adjustment necessary
10 to 30maximum 500 mg twice daily15 mg/kg given twice daily
(maximum 500 mg twice
daily)
less than 10maximum 500 mg/day15 mg/kg given as a single
daily dose (maximum 500
mg)

# In the majority of cases, parenteral therapy is preferred.

In patients receiving haemodialysis

Amoxicillin may be removed from the circulation by haemodialysis.

 Haemodialysis
Adults and children ≥40 kg 15 mg/kg/day given as a single daily dose.

Prior to haemodialysis one additional dose of
15 mg/kg should be administered. In order to
restore circulating drug levels, another dose of
15 mg/kg should be administered after
haemodialysis.

In patients receiving peritoneal dialysis

Amoxicillin maximum 500 mg/day.

Hepatic impairment

Dose with caution and monitor hepatic function at regular intervals (see sections 4.4 and 4.8).

Method of administration

Amoxapen is for oral use.

Absorption of Amoxapen is unimpaired by food.

Therapy can be started parenterally according to the dosing recommendations of the intravenous formulation and continued with an oral preparation.

Swallow with water.

4.9. Overdose

Symptoms and signs of overdose

Gastrointestinal symptoms (such as nausea, vomiting and diarrhoea) and disturbance of the fluid and electrolyte balances may be evident. Amoxicillin crystalluria, in some cases leading to renal failure, has been observed. Convulsions may occur in patients with impaired renal function or in those receiving high doses (see sections 4.4 and 4.8).

Treatment of intoxication

Gastrointestinal symptoms may be treated symptomatically, with attention to the water/electrolyte balance.

Amoxicillin can be removed from the circulation by haemodialysis.

6.3. Shelf life

5 years.

6.4. Special precautions for storage

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label or carton after ‘EXP’. The expiry date refers to the last day of that month.

Store below 25°C. Protect from light and moisture.

6.5. Nature and contents of container

Amoxapen 250 mg film-coated tablets:

PVC/Aluminium blisters. Pack-sizes of 20 film-coated tablets.

PP containers with PE closure. Pack-sizes of 100 and 1000 film-coated tablets.

Amoxapen 500 mg film-coated tablets:

PVC/Aluminium blisters. Pack-sizes of 20, 100 and 1000 film-coated tablets.

PP containers with PE closure. Pack-sizes of 100, 500 and 1000 film-coated tablets.

Not all pack sizes may be marketed.

6.6. Special precautions for disposal and other handling

No special requirements.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.